Pivotal role for a tail subunit of the RNA II mediator complex CgMED2 in azole tolerance and adherence in Candida glabrata

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 10, 2014, Pages 5976-5986

  Borah, Sapan ^a   Shivarathri, Raju ^a   Srivastava, Vivek Kumar ^a   Ferrari, Sélène ^b   Sanglard, Dominique ^b   Kaur, Rupinder ^a  

^a CENTRE FOR DNA FINGERPRINTING AND DIAGNOSTICS   (India)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CASPOFUNGIN; CLOTRIMAZOLE; CYCLIN DEPENDENT KINASE; CYCLOHEXIMIDE; FLUCONAZOLE; KETOCONAZOLE; MEDIATOR COMPLEX; MEDIATOR COMPLEX 2; PROTEIN KINASE C; RNA POLYMERASE II; UNCLASSIFIED DRUG; ANTIFUNGAL AGENT; FUNGAL PROTEIN; PYRROLE DERIVATIVE;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL RESISTANCE; ARTICLE; CANDIDA GLABRATA; CELL ADHESION; CELL SURVIVAL; CELL WALL; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; INVASIVE CANDIDIASIS; MACROPHAGE; MOUSE; NONHUMAN; DRUG EFFECTS; METABOLISM;

ANTIFUNGAL AGENTS; AZOLES; CANDIDA GLABRATA; FUNGAL PROTEINS; RNA POLYMERASE II;

EID: 84907259457     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02786-14     Document Type: Article

References (42)

1. Pfaller MA, Diekema DJ. 2007. Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 20:133-163. http://dx.doi.org/10.1128/CMR.00029-06.
2. Pfaller MA, Moet GJ, Messer SA, Jones RN, Castanheira M. 2011. Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009. Antimicrob. Agents Chemother. 55:561-566. http://dx.doi.org/10.1128/AAC.01079-10.
3. Bassetti M, Mikulska M, Viscoli C. 2010. Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unit. Crit. Care 14:244. http://dx.doi.org/10.1186/cc9239.
4. Wisplinghoff H, Ebbers J, Geurtz L, Stefanik D, Major Y, Edmond MB, Wenzel RP, Seifert H. 2014. Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities. Int. J. Antimicrob. Agents 43:78-81. http://dx.doi.org/10.1016/j.ijantimicag.2013.09.005.
5. Montagna MT, Lovero G, Borghi E, Amato G, Andreoni S, Campion L, Lo Cascio G, Lombardi G, Luzzaro F, Manso E, Mussap M, Pecile P, Perin S, Tangorra E, Tronci M, Iatta R, Morace G. 2014. Candidemia in intensive care unit: a nationwide prospective observational survey (GISIA-3 study) and review of the European literature from 2000 through 2013. Eur. Rev. Med. Pharmacol. Sci. 18:661-674.
6. Yang ZT, Wu L, Liu XY, Zhou M, Li J, Wu JY, Cai Y, Mao EQ, Chen EZ, Lortholary O.2014. Epidemiology, species distribution and outcome of nosocomial Candida spp. bloodstream infection in Shanghai. BMC Infect. Dis. 14:241. http://dx.doi.org/10.1186/1471-2334-14-241.
7. Marie C, White T. 2009. Genetic basis of antifungal drug resistance. Curr. Fungal Infect. Rep. 3:163-169. http://dx.doi.org/10.1007/s12281-009-0021-y.
8. Pfaller MA, Diekema DJ, Jones RN, Messer SA, Hollis RJ, SENTRY Participants Group. 2002. Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000. J. Clin. Microbiol. 40:852-856. http://dx.doi.org/T0.1128/JCM.40.3.852-856.2002.
9. Sanglard D, Ischer F, Calabrese D, Majcherczyk PA, Bille J. 1999. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents. Antimicrob. Agents Chemother. 43:2753-2765.
10. Izumikawa K, Kakeya H, Tsai HF, Grimberg B, Bennett JE. 2003. Function of Candida glabrata ABC transporter gene, PDH1. Yeast 20:249 -261. http://dx.doi.org/10.1002/yea.962.
11. Tscherner M, Schwarzmüller T, Kuchler K. 2011. Pathogenesis and antifungal drug resistance of the human fungal pathogen Candida glabrata. Pharmaceuticals 4:169-186. http://dx.doi.org/10.3390/ph4010169.
12. Tsai HF, Krol AA, Sarti KE, Bennett JE. 2006. Candida glabrata PDR1, a transcriptional regulator of a pleiotropic drug resistance network, mediates azole resistance in clinical isolates and petite mutants. Antimicrob. Agents Chemother. 50:1384-1392. http://dx.doi.org/10.1128/AAC.50.4.1384-1392.2006.
13. Vermitsky JP, Earhart KD, Smith WL, Homayouni R, Edlind TD, Rogers PD. 2006. Pdrl regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies. Mol. Microbiol. 61:704 -722. http://dx.doi.org/10.1111/j.1365-2958.2006.05235.x.
14. Caudle KE, Barker KS, Wiederhold NP, Xu L, Homayouni R, Rogers PD. 2011. Genome-wide expression profile analysis of the Candida glabrata Pdrl regulon. Eukaryot. Cell 10:373-383. http://dx.doi.org/10.1128/EC.00073-30.
15. Paul S, Schmidt JA, Moye-Rowley WS. 2011. Regulation of the CgPdrl transcription factor from the pathogen Candida glabrata. Eukaryot. Cell 10:187-197. http://dx.doi.org/10.1128/EC.00277-10.
16. Thakur JK, Arthanari H, Yang F, Pan SJ, Fan X, Breger J, Frueh DP, Gulshan K, Li DK, Mylonakis E, Struhl K, Moye-Rowley WS, Cormack BP, Wagner G, Näär AM. 2008. A nuclear receptor-like pathway regulating multidrug resistance in fungi. Nature 452:604-609. http://dx.doi.org/10.1038/nature06836.
17. Ferrari S, Ischer F, Calabrese D, Posteraro B, Sanguinetti M, Fadda G, Rohde B, Bauser C, Bader O, Sanglard D. 2009. Gain of function mutations in CgPDRl of Candida glabrata not only mediate antifungal resistance but also enhance virulence. PLoS Pathog. 5:e1000268. http://dx.doi.org/10.1371/journal.ppat.1000268.
18. Casamassimi A, Napoli C. 2007. Mediator complexes and eukaryotic transcription regulation: an overview. Biochimie 89:1439-1446. http://dx.doi.org/10.1016/j.biochi.2007.08.002.
19. Guglielmi B, van Berkum NL, Klapholz B, Bijma T, Boube M, Boschiero C, Bourbon HM, Holstege FC, Werner M. 2004. A high resolution protein interaction map of the yeast Mediator complex. Nucleic Acids Res. 11:5379-5391. http://dx.doi.org/10.1093/nar/gkh878.
20. Gustafsson CM, Samuelsson T. 2001. Mediator-a universal complex in transcriptional regulation. Mol. Microbiol. 41:1-8. http://dx.doi.org/10.1046/j.1365-2958.2001.02481.x.
21. Biddick R, Young ET. 2005. Yeast mediator and its role in transcriptional regulation. C. R. Biol. 328:773-782. http://dx.doi.org/101016/jxrvi.2005.03.004.
22. Myers LC, Gustafsson CM, Bushnell DA, Lui M, Erdjument-Bromage H, Tempst P, Kornberg RD. 1998. The Med proteins of yeast and their function through the RNA polymerase II carboxy-terminal domain. Genes Dev. 12:45-54. http://dx.doi.org/10.1101/gad.12.1.45.
23. Dastidar RG, Hooda J, Shah A, Cao TM, Henke RM, Zhang L. 2012. The nuclear localization of SWI/SNF proteins is subjected to oxygen regulation. Cell Biosci. 2:30. http://dx.doi.org/10.1180/2045-3701-2-30.
24. Peng J, Zhou JQ. 2012. The tail-module of yeast Mediator complex is required for telomere heterochromatin maintenance. Nucleic Acids Res. 40:581-593. http://dx.doi.org/101093/nar/gkr757.
25. Borah S, Shivarathri R, Kaur R. 2011. The Rho1 GTPase-activating protein CgBem2 is required for survival of azole stress in Candida glabrata. J. Biol. Chem. 286:34311-34324. http://dx.doi.org/10.1074/jbc.M111.264673.
26. Kaur R, Ma B, Cormack BP. 2007. A family of glycosylphosphatidylinositol-linked aspartyl proteases is required for virulence of Candida glabrata. Proc. Natl. Acad. Sci. U. S. A. 104:7628-7633. http://dx.doi.org/10.1073/pnas.0611195104.
27. Bairwa G, Kaur R. 2011. A novel role for a glycosylphosphatidylinositolanchored aspartyl protease, CgYpsl, in the regulation of pH homeostasis in Candida glabrata. Mol. Microbiol. 79:900-913. http://dx.doi.org/10.1111/j.1365-2958.2030.07496.x.
28. Kaur R, Castaño I, Cormack BP. 2004. Functional genomic analysis of fluconazole susceptibility in the pathogenic yeast Candida glabrata: roles of calcium signaling and mitochondria. Antimicrob. Agents Chemother. 48:1600-1613. http://dx.doi.org/10.1128/AAC.48.51600-1613.2004.
29. Tsai HF, Sammons LR, Zhang X, Suffis SD, Su Q, Myers TG, Marr KA, Bennett JE. 2010. Microarray and molecular analyses of the azole resistance mechanism in Candida glabrata oropharyngeal isolates. Antimicrob. Agents Chemother. 54:3308-3317. http://dx.doi.org/10.1128/AAC.00535-10.
30. Kaur R, Domergue R, Zupancic ML, Cormack BP. 2005. A yeast by any other name: Candida glabrata and its interaction with the host. Curr. Opin. Microbiol. 8:378-384. http://dx.doi.org/101016/j.mib.2005.06.012.
31. Vale-Silva L, Ischer F, Leibundgut-Landmann S, Sanglard D. 2013. Gain-of-function mutations in PDR1, a regulator of antifungal drug resistance in Candida glabrata, control adherence to host cells. Infect. Immun. 81:1709-1720. http://dx.doi.org/10.1128/IAI.00074-13.
32. Cormack BP, Ghori N, Falkow S. 1999. An adhesin of the yeast pathogen Candida glabrata mediating adherence to human epithelial cells. Science 285:578-582. http://dx.doi.org/10.1126/science.285.5427.578.
33. Castaño I, Pan S-J, Zupancic M, Hennequin C, Dujon B, Cormack BP. 2005. Telomere length control and transcriptional regulation of subtelomeric adhesins in Candida glabrata. Mol. Microbiol. 55:1246-1258. http://dx.doi.org/10.1111/j.1365-2958.2004.04465.x.
34. Uwamahoro N, Qu Y, Jelicic B, Lo TL, Beaurepaire C, Bantun F, Quenault T, Boag PR, Ramm G, Callaghan J, Beilharz TH, Nantel A, Peleg AY, Traven A. 2012. The functions of Mediator in Candida albicans support a role in shaping species-specific gene expression. PLoS Genet. 8:e 1002613. http://dx.doi.org/10T371/journal.pgen.3002633.
35. Alexander BD, Johnson MD, Pfeiffer CD, Jimenez-Ortigosa C, Catania J, Booker R, Castanheira M, Messer SA, Perlin DS, Pfaller MA. 2013. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin. Infect. Dis. 56:1724-1732. http://dx.doi.org/10.1093/cid/cit136.
36. Levin DE. 2005. Cell wall integrity signaling in Saccharomyces cerevisiae. Microbiol. Mol. Biol. Rev. 69:262-291. http://dx.doi.org/10.1128/MMBR.69.2.262-291.2005.
37. Shahi P, Gulshan K, Näär AM, Moye-Rowley WS. 2010. Differential roles of transcriptional mediator subunits in regulation of multidrug re- sistance gene expression in Saccharomyces cerevisiae. Mol. Biol. Cell 21: 2469-2482. http://dx.doi.org/10.1091/mbc.E09-10-0899.
38. Zhang F, Sumibcay L, Hinnebusch AG, Swanson MJ. 2004. A triad of subunits from the Gall 1/tail domain of Srb mediator is an in vivo target of transcriptional activator Gcn4p. Mol. Cell. Biol. 24:6871-6886. http://dx.doi.org/10.1128/MCB.24.15.6871-6886.2004.
39. Ferrari S, Sanguinetti M, Torelli R, Posteraro B, Sanglard D. 2011. Contribution of CgPDR1-regulated genes in enhanced virulence of azoleresistant Candida glabrata. PLoS One 6:e17589. http://dx.doi.org/10.1371/journal.pone.0017589.
40. Zhu X, Liu B, Carlsten JO, Beve J, Nyström T, Myers LC, Gustafsson CM. 2011. Mediator influences telomeric silencing and cellular life span. Mol. Cell. Biol. 31:2413-2421. http://dx.doi.org/10.1128/MCB.05242-11.
41. Liu Z, Myers LC. 2012. Med5 (Nut1) and Med 17 (Srb4) are direct targets of mediator histone H4 tail interactions. PLoS One 7:e38416. http://dx.doi.org/10.1371/journal.pone.0038416.
42. Zhang A, Liu Z, Myers LC. 2013. Differential regulation of white-opaque switching by individual subunits of Candida albicans mediator. Eukaryot. Cell 12:1293-1304. http://dx.doi.org/10.112S/EC.00137-13.